[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100549953":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":55,"collaborators":25,"id":58,"slug":25,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":25,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":25,"enrollmentInfo":66,"targetDuration":25,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":25,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Universiti Sains Malaysia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"oXiris filter","EXPERIMENTAL","Continuous Renal Replacement Therapy with the adsorption membrane filter Oxiris.\n\nThe specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared.\n\nThe 28-day mortality will be recorded following treatment.",[13],"Device: oXiris filter",{"label":15,"type":16,"description":17,"interventionNames":18},"M100 filter","ACTIVE_COMPARATOR","Continuous Renal Replacement Therapy with the adsorption membrane filter M100. The specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared.\n\nThe 28-day mortality will be recorded following treatment.",[19],"Device: M100 filter",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Continuous Renal Replacement Therapy with the adsorption membrane filter Oxiris.\n\nThe specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"Continuous Renal Replacement Therapy with the adsorption membrane filter M100. The specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Marina Azidah Mat Zaid, MBBS","CONTACT","0199870715","marinazaid@yahoo.com",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Hospital Universiti Sains Malaysia (HUSM)","RECRUITING","Kubang Kerian","Kelantan","16150","Malaysia",{"type":44,"coordinates":45},"Point",[46,47],102.27938,6.09123,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":52,"phoneExt":53,"email":54},"Mohd Zulfakar Mazlan, MBBS","+6097673000","6104","zulfakar@usm.my",{"type":56,"investigatorFullName":51,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"SPONSOR_INVESTIGATOR","Associate Professor","100549953",false,"NCT06440759","To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT","Evaluation of Efficacy and Safety Using oXiris Versus M100 Filter in Pneumonia-induced Acute Kidney Injury (AKI) Patients Requiring Continuous Renal Replacement Therapy (CRRT)","Inclusion Criteria:\n\n* All adult patients aged\\>18 years old\n* Diagnosis of septic shock\n* Diagnosis of KDIGO stage 3 acute renal failure\n\nExclusion Criteria:\n\n* Moribund patient or patient that is expected to die within 72 hours\n* Pregnancy\n* patient with a bleeding tendency or known allergy to heparin","ALL","18 Years",{"count":67,"type":68},60,"ESTIMATED","INTERVENTIONAL",[71],"NA","The purpose of this study aimed to compare the efficacy of Oxiris (Baxter) and M100 filters on IL-6 as primary outcomes and other blood cell counts, blood biochemistry (serum urea, creatinine, potassium, sodium), inflammation indicators (CRP, PCT), as secondary outcomes and safety (28 days mortality as a primary outcome and coagulopathy, lifespan of filter, usage of vasopressor, clinical conditions (ventilator-free days, ICU and hospital- length of stay) as a secondary outcome), clinical conditions (ventilator-free days, ICU and hospital- length of stay), and mortality of patients with pneumonia-related AKI.",[74,75],"AKI - Acute Kidney Injury","Pneumonia","2025-09-30",{"date":78,"type":79},"2025-10-02","ACTUAL",{"date":81,"type":79},"2024-05-30",{"date":83,"type":68},"2026-05-01",{"name":51,"class":6},1]